Carrelizumab Plus Lenvatinib Combined With TACE

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Carrelizumab Plus Lenvatinib Combined With TACE trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 1/2

NCT05042336

The Effectiveness and Safety of Camrelizumab/Lenvatinib Combined With TACE in Patients With Borderline Resectable HCC

The effectiveness and safety of carmelizumab/lenvatinib combined with TACE in patients with borderline resectable hepatocellular carcinoma remain unknown. This…

China49 participantsStarted 2021-09-01

Treatment: camrelizumab/lenvatinib combined with TACE